Award

2009-1-rt-03-us-1

Funder: Institut National Du Cancer

Funded outputs count: 6

Funder award ID: 2009-1-RT-03-US-1

OpenAlex ID: G3441602114

Circulating tumor DNA is a prognostic marker of tumor recurrence in stage II and III colorectal cancer: multicentric, prospective cohort study (ALGECOLS)

2021 · Leonor Benhaim, Olivier Bouché, et al. · European Journal of Cancer · 61

Characterization of Plasma Cell-Free DNA Integrity Using Droplet-Based Digital PCR: Toward the Development of Circulating Tumor DNA-Dedicated Assays

2021 · Geoffroy Poulet, Fanny Garlan, et al. · Frontiers in Oncology · 11

Plasma clearance ofRASmutation under therapeutic pressure is a rare event in metastatic colorectal cancer

2019 · Emilie Moati, Hélène Blons, et al. · International Journal of Cancer · 43

Multiplex Detection of Rare Mutations by Picoliter Droplet Based Digital PCR: Sensitivity and Specificity Considerations

2016 · Eleonora Zonta, Fanny Garlan, et al. · PLoS ONE · 103

A Study of Hypermethylated Circulating Tumor DNA as a Universal Colorectal Cancer Biomarker

2016 · Sonia Garrigou, Geraldine Perkins, et al. · Clinical Chemistry · 149

Multiplex Picodroplet Digital PCR to Detect KRAS Mutations in Circulating DNA from the Plasma of Colorectal Cancer Patients

2013 · Valerie Taly, Deniz Pekin, et al. · Clinical Chemistry · 511